MYP_110131
Basic Information
IL-36 receptor antagonist
Immunology Immune modulation Immunomodulatory activity
Neurological / Signaling Receptor modulation Agonist
Neurological / Signaling Receptor modulation Antagonist
Neurological / Signaling Signaling peptide
Standard
155 amino acids
C761H1181N197O224S9
Standard
Sequence
MVLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWLDASLSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRRDMGLTSSFESAAYPGWFLCTVPEADQPVRLTQLPENGGWNAPITDFYFQQCD
Physicochemical Analysis
16962.29 Da
5.12
-4.35
-4.78
-0.0281
0.03
0.52
0.14
60.09
89.94
0.0968
23950.00
24200.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
6684.24
-62.47
231.0
231.0
550.0
1191.0
29.0
168.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0167137 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
GtoPdb endogenous peptide ligand
9606
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
reported in GtoPdb PTM annotation
Predicted disulphide bond formation between cysteinen residues at positions 8 and 154.
Bio-Activity Profile
Receptor antagonist Immunomodulatory Signaling peptide
Interleukin-36 receptor (Human)